These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7521509)
21. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571 [TBL] [Abstract][Full Text] [Related]
22. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients. Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells. Bonavida B; Katz J; Hoshino T Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275 [TBL] [Abstract][Full Text] [Related]
24. Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Rabinowich H; Sedlmayr P; Herberman RB; Whiteside TL Cell Immunol; 1991 Jul; 135(2):454-70. PubMed ID: 1709827 [TBL] [Abstract][Full Text] [Related]
25. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy. Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787 [TBL] [Abstract][Full Text] [Related]
26. Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Musha N; Yoshida Y; Sugahara S; Yamagiwa S; Koya T; Watanabe H; Hatakeyama K; Abo T Clin Exp Immunol; 1998 Aug; 113(2):220-8. PubMed ID: 9717971 [TBL] [Abstract][Full Text] [Related]
28. Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation. Lafreniere R; Borkenhagen K; Bryant LD; Ng E; Hayton S J Biol Response Mod; 1990 Feb; 9(1):53-60. PubMed ID: 2181072 [TBL] [Abstract][Full Text] [Related]
29. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Clausen J; Vergeiner B; Enk M; Petzer AL; Gastl G; Gunsilius E Immunobiology; 2003; 207(2):85-93. PubMed ID: 12675266 [TBL] [Abstract][Full Text] [Related]
30. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells. Condiotti R; Nagler A Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131 [TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis on perforin induction in peripheral blood mononuclear cells with interleukin-2 or OK-432. Kataoka K; Naomoto Y; Kojima K; Horiki S; Hizuta A; Tanaka N; Yahagi N; Miyazaki Y; Okumura K; Orita K J Immunother (1991); 1992 May; 11(4):249-56. PubMed ID: 1599910 [TBL] [Abstract][Full Text] [Related]
32. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. Lebow LT; Jewett A; Bonavida B J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130 [TBL] [Abstract][Full Text] [Related]
33. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974 [TBL] [Abstract][Full Text] [Related]
34. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity. Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337 [TBL] [Abstract][Full Text] [Related]
35. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC; Hsiao MH; Pattengale PK Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400 [TBL] [Abstract][Full Text] [Related]
37. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. Itoh K; Tilden AB; Kumagai K; Balch CM J Immunol; 1985 Feb; 134(2):802-7. PubMed ID: 3917475 [TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. Goodier MR; Londei M J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046 [TBL] [Abstract][Full Text] [Related]
39. Different sensitivity to interleukin 4 of interleukin 2- and interferon alpha-induced CD69 antigen expression in human resting NK cells and CD3+, CD4-, CD8- lymphocytes. Gerosa F; Tommasi M; Carra G; Gandini G; Tridente G; Benati C Cell Immunol; 1992 May; 141(2):342-51. PubMed ID: 1533569 [TBL] [Abstract][Full Text] [Related]
40. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood. Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]